Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Rubic-Schneider

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Toxicologic Pathology|February 4, 2016
Minipigs in Translational Immunosafety Sciences: A PerspectiveTina Rubic-Schneider, Brigitte Christen, Dominique Brees, et al.
Toxicologic Pathology|June 22, 2022
Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology StudyThierry D Flandre, Keith G Mansfield, Pascal J Espié, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 13, 2018
Nonclinical Safety Assessment of CFZ533, a Fc-Silent Anti-CD40 Antibody, in Cynomolgus MonkeysPeter Ulrich, Thierry Flandre, Pascal Espie, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2018
Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiativeJacques Descotes, Linda Allais, Philippe Ancian, et al.
Blood Advances|January 4, 2018
T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasiaTina Rubic-Schneider, Masataka Kuwana, Brigitte Christen, et al.
The Journal of Experimental Medicine|August 3, 2016
GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritisAmanda Littlewood-Evans, Sophie Sarret, Verena Apfel, et al.
Molecular Therapy. Methods & Clinical Development|November 10, 2025
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
JCI Insight|March 15, 2017
Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrationsChristine Guntermann, Alessandro Piaia, Marie-Laure Hamel, et al.
Frontiers in Immunology|May 20, 2020
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like PathologyKea Martin, Ursula Junker, Elaine Tritto, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|February 4, 2016
Minipigs in Translational Immunosafety Sciences: A PerspectiveTina Rubic-Schneider, Brigitte Christen, Dominique Brees, et al.
Toxicologic Pathology|June 22, 2022
Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology StudyThierry D Flandre, Keith G Mansfield, Pascal J Espié, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 13, 2018
Nonclinical Safety Assessment of CFZ533, a Fc-Silent Anti-CD40 Antibody, in Cynomolgus MonkeysPeter Ulrich, Thierry Flandre, Pascal Espie, et al.
Regulatory Toxicology and Pharmacology : RTP|February 27, 2018
Nonclinical evaluation of immunological safety in Göttingen Minipigs: The CONFIRM initiativeJacques Descotes, Linda Allais, Philippe Ancian, et al.
Blood Advances|January 4, 2018
T-cell assays confirm immunogenicity of tungsten-induced erythropoietin aggregates associated with pure red cell aplasiaTina Rubic-Schneider, Masataka Kuwana, Brigitte Christen, et al.
The Journal of Experimental Medicine|August 3, 2016
GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritisAmanda Littlewood-Evans, Sophie Sarret, Verena Apfel, et al.
Molecular Therapy. Methods & Clinical Development|November 10, 2025
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vectorintrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
Molecular Therapy. Advances|May 15, 2026
Erratum: Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeysMaria Vono, Tony Del Rio, Eduardo Magdaleno, et al.
JCI Insight|March 15, 2017
Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrationsChristine Guntermann, Alessandro Piaia, Marie-Laure Hamel, et al.
Frontiers in Immunology|May 20, 2020
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like PathologyKea Martin, Ursula Junker, Elaine Tritto, et al.
Pageof 2